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Abstract 
The tricyclic cytosine, tC, is a fluorescent base analogue with excellent properties for 
investigating intrinsic characteristics of nucleic acid as well as interactions between 
nucleic acids and other molecules. Its unique fluorescence properties and insignificant 
influence on overall structure and dynamics of nucleic acid after incorporation makes tC 
particularly interesting in fluorescence resonance energy transfer (FRET) and anisotropy 
measurements. We here describe a straightforward synthesis of the standard monomer 
form of tC for DNA solid phase synthesis, the tC phosphoramidite, and its subsequent 
incorporation into oligonucleotides. The total synthesis of the tC phosphoramidite takes 
approximately eight days and its incorporation and the subsequent oligonucleotide 
purification an additional day. 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
Fluorescent studies both at the ensemble and single molecule level are at the fore of 
biochemical as well as biophysical research and will increase in importance in the 
expanding field of bionanotechnology as the constructs keep decreasing in dimensions. 
As one of the most sensitive and versatile analytical techniques available for examining 
biological processes and biochemical mechanisms, fluorescence has found use in e.g. 
single molecule real-time dynamics of nucleic acid as well as protein, cell microscopy, 
nucleic acid detection and nucleic acid-protein interaction measurements. In these kinds 
of studies the intrinsically virtually non-fluorescent DNA or RNA has to be covalently or 
non-covalently modified with a fluorophore. For investigations where the level of detail 
needs to be high, a modification in which a fluorescent base analogue is covalently 
incorporated is generally preferable since this minimises perturbations to the native 
structure and behaviour of the nucleic acid. Furthermore, using fluorescent base 
analogues enables the probe to be very close to the site of examination compared to 
fluorescent molecules that are tethered to DNA via long linkers. 
 Several fluorescent base analogues have been developed and later also used as 
probes.
1-3
 The emission quantum yield and lifetime of a great majority of those, e.g. 2-
aminopurine,
4, 5
 3- and 6-methylisoxanthopterin (3-MI and 6-MI),
6-8
 6MAP and DMAP,
9, 
10
 as well as pyrrolo-dC,
11
 are highly sensitive to microenvironment. Incorporation of 
these analogues into B-DNA leads to a significant decrease in quantum yield and excited 
state lifetime. This has been utilized in studies of both structure and dynamics within 
DNA and RNA
12, 13
 as well as in measurements of kinetics of DNA-protein interaction
14-
18
. We have developed a fluorescent base analogue, tricyclic cytosine (tC), that in contrast 
has a high emission quantum yield (f=0.2) that is virtually insensitive to neighbouring 
base combination and to changes from single- to double-stranded structures.
19-21
 
Furthermore, the emission of tC incorporated into DNA is characterized by a single 
exponential decay in both single and double strands.
21
 In combination with a firm 
stacking, excellent base-pairing, preservation of DNA secondary structure (B-form) and a 
slight stabilization of duplexes this makes tC unprecedented as a fluorescent probe in 
nucleic acid containing systems.
22
 Since properties like a high quantum yield, a single 
lifetime as well as a rigid and well-defined geometry considerably simplifies both 
measuring and evaluation of fluorescence resonance energy transfer (FRET) and 
fluorescence anisotropy, one can envisage previously practically impossible experiments 
that have become achievable thanks to tC. One could for example use tC as a probe for 
very accurately measuring the hydrodynamic radii of various nucleic acid structures as 
well as the binding of proteins or smaller DNA binding molecules to DNA using 
anisotropy. For other fluorescent base analogues a low emission quantum yield, a 
multiexponential emission decay and a weak base-pairing (fast base flipping), resulting in 
characteristic diffusion times corresponding to the intrinsic mobility of the base analogue, 
drastically complicates evaluation of this kind of data. As another example, one can also 
envisage using tC-DNA in combination with a FRET acceptor modified protein to study 
exact distances within the DNA-protein complex. Exact distance estimates using FRET 
rely heavily on accurate calculation of the Förster distance (R0), which in turn depends 
upon among other things the donor quantum yield and the relative orientation of donor 
and acceptor. Currently tC is the only fluorescent base analogue exhibiting an 
environment insensitive emission quantum yield with a low base flipping rate. 
Consequently, distances determined using tC will be significantly more accurate than 
those using other available fluorescent base analogues. 
  This protocol presents the preparation of the phosphoramidite form of tC and its 
subsequent incorporation into oligonucleotides. A very convenient synthetic route based 
on the sodium salt glycosylation procedure
23
 is presented (Fig. 2, step a), in which the 
starting materials 2
24, 25
 (Fig. 1) and the protected 2-deoxyribosyl chloride are stable and 
can easily be prepared in gram quantities. 2-deoxyribosyl chloride is commercially 
available but is expensive and the synthetic procedure from 2-deoxy-D-ribose is 
uncomplicated and high yielding.
26
 From the two starting materials the phosphoramidite, 
6, is achieved in four straightforward steps. The synthetic effort needed to reach the tC 
phosphoramidite, especially in the purification steps, is significantly reduced from a 
previous synthetic route.
27
 The relatively modest yield of 6 from 2 (~7 %) is made up for 
by the simplicity by which it can be synthesised and the inexpensive starting materials. 
Furthermore, the protocol presents details for the activation and incorporation of this 
specialised phosphoramidite monomer, a piece of information that is of general 
importance as the need for nucleic acids that contain novel base analogues keeps 
increasing. 
 
 
 
 
 
 
MATERIALS 
REAGENTS 
 2-aminothiophenol (Sigma-Aldrich, cat. no. 274240) 
 5-bromouracil (Acros Organics, cat. no. 226440250) 
 2-deoxy-3,5-di-O-p-toluoyl--D-ribofuranosyl chloride  (Prepared as described 
elsewhere.
26
 Can be purchase from Sigma-Aldrich, cat. no. D7283-1G) 
 4,4'-dimethoxytrityl chloride (Link technologies, cat. no. 0021-C000) 
 N,N-diisopropylethylamine (Sigma-Aldrich, cat. no. 387649) CAUTION Highly 
flammable 
 2-cyanoethyl-N,N-diisopropylchlorophosphoramidite (Link Technologies, cat. no. 
1028-C010) 
 Sodium hydride (60 % dispersion in mineral oil) (Sigma-Aldrich, cat. no. 452912) 
CAUTION Highly flammable 
 Ethylene glycol (Sigma-Aldrich, cat. no. 324558) 
 N,N-Dimethylformamide, over molecular sieve (Fluka, cat. no. 40228) 
 Chloroform (Riedel-de Haën, cat. no. 32211) 
 Silica gel 60 (0.040-0.063 mm) (Merck, cat. no. 1.09385) 
 Sand (Merck, cat. no. 1.07712.1000) 
 TLC aluminium sheets, Silica gel 60 F254 (Merck, cat. no. 1.05554.0001) 
 Pyridine CAUTION Highly flammable 
 Ethyl acetate CAUTION Highly flammable 
 Methanol dry CAUTION Highly flammable 
 Methanol CAUTION Highly flammable 
 Dichloromethane 
 Dichloromethane, alcohol free 
 Aqueous ammonia solution 25% 
 Acetic acid, glacial 
 Diethyl ether CAUTION Highly flammable 
 Toluene CAUTION Highly flammable 
 Tetrahydrofuran CAUTION Highly flammable 
 Acetonitrile CAUTION Highly flammable 
 Hydrochloric acid, 37% CAUTION Corrosive 
 Ethanol 95,5% CAUTION Highly flammable 
 Ethanol 99,7% CAUTION Highly flammable 
 Sodium carbonate anhydrous  
 Sodium hydroxide CAUTION Corrosive 
 Potassium hydroxide CAUTION Corrosive 
 Sodium hydrogen carbonate 
 Sodium chloride 
 Sodium sulphate anhydrous 
 Magnesium sulphate anhydrous 
 Potassium chloride 
 Calcium hydride anhydrous CAUTION Highly flammable 
 Sodium metal CAUTION Highly flammable 
 A, G, C, T phosphoramidite monomers (Proligo: Sigma Aldrich - SAFC) 
 Tetrazole coupling catalyst (Applied Biosystems) 
 Acetic anhydride and N-methyl imidazole capping reagents (Applied Biosystems) 
 3% trichloroacetic acid in dichloromethane deprotection solution (Applied 
Biosystems) 
 1% iodine oxidation mixture in tetrahydrofuran (Applied Biosystems) 
 Acetonitrile wash solvent (Rathburn Chemical Ltd) 
 Aqueous ammonia cleavage solution (Fischer Scientific) 
 HPLC elution buffer A: 0.1 M aqueous ammonium acetate (Fischer Scientific) 
 HPLC elution buffer B: 0.1 M aqueous ammonium acetate, 25% acetonitrile (Fischer 
Scientific and Rathburn Chemical Ltd, respectively) 
 
EQUIPMENT 
 Hotplate magnetic stirrer with temperature controller 
 Oil bath 
 pH indicator paper 
 Water cooled condenser 
 Dual nitrogen-vacuum manifold with vacuum pump 
 Argon gas 
 Glass frit funnels (10-15 m and 4-10 m porosity) 
 Vacuum desiccator 
 Separating funnel (500 ml) 
 Rotary evaporator 
 Glass and plastic syringes 
 Reusable stainless steel syringe needles and disposable syringe needles 
 Round-bottom flasks (250 ml, 100 ml, 25 ml and 10 ml) 
 Two-neck round-bottom flask (250 ml) 
 Pear-shaped flask (5 ml) 
 UV-lamp (365nm) 
 Columns for chromatography (50 x 1.5 cm, 25 x 4 cm, 55 x 5.5 cm) 
 Disposable glass Pasteur pipettes 
 0.45 micron filter 
 Automated DNA synthesizer (Applied Biosystems ABI 394) 
 Monomer bottles (of types used in Automated DNA synthesizer) 
 ABI Aquapore column (C8), 8 mm x 250 mm, pore size 300 Å 
 Brownlee Aquapore (C8) reversed-phase column (10 mm x 25 cm) from Perkin 
Elmer 
 NAP-10 column (Sephadex G-25, Pharmacia) 
 
REAGENT SETUP 
Where necessary (see relevant steps in the body of the procedure), moisture-free pyridine, 
dichloromethane, tetrahydrofuran and diisopropylamine were obtained by distillation: 
- Pyridine and dichloromethane (alcohol free) are distilled over CaH2. 
- Tetrahydrofuran is distilled over sodium CAUTION Sodium metal is highly 
flammable 
- Diisopropylamine is distilled over KOH pellets 
Moisture-free, and degassed ethyl acetate was obtained by adding anhydrous magnesium 
sulphate (1 g per 100ml) to the ethyl acetate in a suitable sized conical flask. Swirl 
around the mixture, leave to stand for 5 minutes and then decant the ethyl acetate into a 
second conical flask, leaving the magnesium sulphate behind. Degas by bubbling a steady 
stream of argon gas through the ethyl acetate for 2 minutes. This procedure ensures that 
excess moisture and oxygen is removed from the ethyl acetate. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PROCEDURE 
Synthesis of starting material 1,3-diaza-2-oxophenothiazine (2) 
1 Weigh out 8.4 g (67 mmol) 2-aminothiophenol, 9.5 g (50 mmol) 5-bromouracil and 
5.3 g (50 mmol) Na2CO3 into a 250 ml round-bottom flask. Add 30 ml of ethylene 
glycol and a magnetic stir bar to the flask. 
2 Bubble argon gas through the mixture for 30 s. 
3 Fit the flask with the water cooled condenser fitted with a rubber septum at the top. 
Insert an argon inlet and a vent consisting of a disposable syringe needle into the 
rubber septum. 
4 Turn on a fairly strong argon flow to purge the flask and then reduce the flow to a 
minimum. 
5 Turn on the water to the condenser and the magnetic stirrer. Heat the mixture to 
120C in an oil bath and stir the reaction mixture for 1 h. 
CRITICAL STEP The temperature and reaction time are important. Increasing 
reaction times and temperatures decrease the yield of the reaction. 
6 Cool the reaction to room temperature (a precipitate is formed). 
7 While stirring, slowly add ~90 ml H2O to the mixture. 
8 Neutralize the mixture with ~3 ml acetic acid (check pH using pH indicator paper). 
9 Filter the mixture through a glass frit funnel (porosity 10-16 m). Wash the 
precipitate, first with water and then with a large volume of ethanol until the filtrate, 
initially dark yellow, becomes colourless and finally with a small volume of ether to 
facilitate drying. The white precipitate will be used in 11. 
10 Dissolve 2 g of sodium hydroxide in 100 ml of water containing a magnetic stir bar 
and heat the solution to ~50C while stirring. 
11 The white precipitate of the crude product 1 from step 9 is added in portions to the 
heated solution. 
12 When everything is dissolved, the clear solution is neutralized by dropwise addition 
of acetic acid (check pH ~7 by using pH test paper). A white precipitate is formed. 
13 The hot suspension is filtered through a glass frit funnel (porosity 10-16 m). Wash 
the precipitate (1) well, first with water and then with ethanol and finally with ether 
and dry it in a vacuum desiccator. 
14 Carefully add 7.3 ml HCl (37%) to a 250 ml round-bottom flask containing 73 ml 
ethanol (95.5%) and a magnetic stir bar. Weigh out 3.6 g (15 mmol) of 1 and while 
stirring, add it in portions to the flask. Fit the flask with a water cooled condenser, 
turn the water on, and heat the reaction to 80C using an oil bath. PAUSE POINT 
Leave the reaction mixture to stir at 80C for ~24 h. (A white precipitate of 1HCl 
often forms after 1 has dissolved. The precipitate gradually changes colour as the 
product 2HCl is formed as a mass of thin yellow crystal needles.) 
15 Let the reaction cool to room temperature and filter the mixture through a glass frit 
funnel (porosity 10-16 m). 
16 To prepare the free base of 2 (2HCl2), add the precipitate to a stirred, warm (50C) 
aqueous 5% ammonia solution. The yellow crystals turn into a pale yellow 
microcrystalline precipitate. After 5 min., filter the hot mixture through a glass frit 
(porosity 4-10 m). 
17 Repeat step 16 with the isolated precipitate from step 16. 
18 Wash the yellow product 2 well with water. PAUSE POINT Dry product over night 
in an oven at ~80C. Product 2 can be stored in room temperature for at least two 
years. 
 
Synthesis of 3-[2-deoxy-3-O-[2-cyanoethoxy-(N,N-diisopropylamino)-phosphino]-5-
O-(4,4’-dimethoxytrityl)--D-ribofuranosyl]-1,3-diaza-2-oxophenothiazine (6). 
19 Add 1.0 g (4.6 mmol) of 2 into a 250 ml two-neck, round-bottom flask containing a 
magnetic stir bar. Add 2.1 g (5.4 mmol) 2-deoxy-3,5-di-O-p-toluoyl--D-
ribofuranosyl chloride to a small glass beaker and put it into a vacuum desiccator. 
20 Fit the round-bottom flask with a gas-inlet adapter and a rubber septum. Attach the 
gas-inlet adapter and the vacuum desiccator to a vacuum/nitrogen manifold. PAUSE 
POINT Leave the substances under vacuum over night to dry. 
21 Release the vacuum to the round-bottom flask with a flow of nitrogen. Add 60 ml of 
dry DMF, freshly opened, to the flask using a plastic syringe with a disposable 
syringe needle. Turn on the magnetic stirrer. 
22 Add 0.203 g (5.1 mmol) NaH (60% in mineral oil) to the suspension and wait until a 
clear solution is obtained. If the suspension has not dissolved in ~1 h, heat the 
suspension gently with a water-bath containing hot water from the tap. Once a clear 
solution is obtained, take away the warm water-bath and let the solution cool to room 
temperature. 
23 Increase the flow of nitrogen to the flask and remove the rubber septum. Add the 2-
deoxy-3,5-di-O-p-toluoyl--D-ribofuranosyl chloride in portions (~4 portions over 
~30 min.) to the solution (recap the flask between each addition). (A precipitate is 
formed at the end of the addition.) 
CRITICAL STEP 2-deoxy-3,5-di-O-p-toluoyl--D-ribofuranosyl chloride is 
unstable in DMF. Therefore, it should be added as a solid and not dissolved in DMF. 
24 Continue stirring for 2 h. Remove the nitrogen inlet and filter the solution through a 
glass frit funnel. Discard the precipitate on the filter and transfer the filtrate to a 250 
ml round-bottom flask and concentrate it to an oil using a rotary evaporator (40C) 
connected to a vacuum pump. 
25 Add 150 ml of ethyl acetate to the concentrate. After gentle warming (appr. 50C) 
and sonication using an ultrasonic bath, filter off any undissolved substance using a 
glass frit funnel (porosity 4-10 m). Transfer the filtrate to a separatory funnel and 
wash the ethyl acetate solution with saturated NaHCO3 (5 x 100 ml) and saturated 
sodium chloride (1 x 100 ml). Dry the ethyl acetate phase with anhydrous sodium 
sulphate (add the sodium sulphate to a stirred solution in aliquots of ~0.5g until the 
organic solution appears to be clear. Leave for at least 5 minutes before filtering). 
26 Filter off the sodium sulphate using a frit funnel and transfer the filtrate to a round-
bottom flask. 
27 Evaporate the ethyl acetate using a rotary evaporator at 40C. 
PAUSE POINT The product can be left overnight in a refrigerator 
28 Pack a chromatography column (55 x 5.5 cm) with ~150 g silica gel using 0.5% 
(vol/vol) methanol in dichloromethane. 
29 Add 100 ml of ethyl acetate to dissolve the crude mixture and add silica gel (~45 g). 
Evaporate the ethyl acetate using a rotary evaporator at 40C. 
30 Load the crude mixture adsorbed to the silica on top of the silica gel column using a 
long-stemmed powder funnel. Cover the top of the column with a layer of sand (~1 
cm thick). 
31 Elute the column under gravity or under slight pressure with solvent mixtures with 
increasing amount of methanol in dichloromethane, 1 l each of 0.5%, 1% and 2% 
(vol/vol) methanol. Start collecting 50 ml fractions after about ~1.5 l of solvent has 
run through. The bands can be visualized on the column by fluorescence using a 365 
nm UV-lamp (the bands are also coloured yellow but it is easier to identify the 
different bands by fluorescence). 
CAUTION Be careful when using the UV-lamp. UV-light is harmful to eyes. 
32 Identify fractions containing the mixture of the - and -anomers of the protected 
nucleoside 3 by TLC. Use thin-layer silica gel on aluminium support with 5 % 
(vol/vol) methanol in dichloromethane (Rf = 0.3 for the -anomer, Rf = 0.2 for the - 
anomer). The bands are visualized by fluorescence using a 365 nm UV-lamp. (The 
anomeric mixture is isolated since the - and -anomer separates poorly at this stage. 
The two anomers are separated after deprotection.) 
33 Evaporate the solvent from the pooled fractions containing the - and -anomeric 
mixture using rotary evaporator at 40C and dry the residual oil in a 100 ml round-
bottom flask for a few hours using a vacuum pump. 
34 Dissolve a cleanly cut piece of sodium (50 mg) in 50 ml of dry methanol. By using a 
plastic syringe with a disposable syringe needle, add the sodium methoxid solution (2 
eq. MeONa) and a magnetic stir bar to the round-bottom flask containing ~600 mg 
(~1 mmol) of the /-mixture 3. 
CAUTION Sodium metal reacts violently with water and alcohols to produce the 
highly flammable and explosive hydrogen gas. Use caution when adding sodium to 
methanol! Carry out this experiment in a fume hood and make sure there are no open 
flames in the vicinity. 
35 Cover the flask with aluminium foil and turn on the stirring. PAUSE POINT Stir the 
solution over night at room temperature. 
36 Add ~0.5 ml acetic acid to stop the reaction. Remove the magnetic stir bar and 
evaporate the reaction to dryness using a rotary evaporator at 40C. 
37 Add 30 ml of methanol to dissolve the crude product and transfer the solution to a 
250 ml round-bottom flask. Add another 70 ml methanol together with silica gel (~13 
g) and evaporate the methanol using a rotary evaporator at 40 C. 
38 Pack a chromatography column (55 x 5.5 cm) with ~100 g silica gel using 5% 
(vol/vol) ethanol (99.7%) in chloroform. 
39 Load the crude mixture adsorbed to the silica from step 37 on top of the silica gel 
column using a long-stemmed powder funnel. Cover the top of the column with a 
layer of sand (~1 cm thick). 
40 Run through 200 ml of 5 % (vol/vol) ethanol in chloroform and then increase the 
ethanol to 9% (vol/vol). Start collecting ~45 ml fractions after running ~1 l of solvent 
through. The bands are visualized by fluorescence using a 365 nm UV-lamp or by 
colour (yellow). This provides information of when to start to collect fractions. 
41 Identify the fraction containing the -nucleoside, 4, by TLC. Use thin-layer silica gel 
on aluminium support with 15 % (vol/vol) ethanol in chloroform (Rf = 0.25 for the -
anomer, Rf = 0.15 for the - anomer). The bands are visualized by fluorescence using 
a 365 nm UV-lamp. 
42 Evaporate the solvent from the pooled fractions containing 4 using rotary evaporator 
at room temperature. PAUSE POINT Dry the crystalline product over night using a 
vacuum pump. Product 4 can be stored at room temperature in the dark for several 
years. 
43 Add 166 mg (0.49 mmol) of 4,4’-dimethoxytrityl chloride to a 5 ml pear-shaped 
flask. 
44 Add 150 mg (0.45 mmol) of 4 to a 10 ml round-bottom flask containing a magnetic 
stir bar. 
45 Fit both flasks with a gas-inlet adapter and attach them to a vacuum/nitrogen 
manifold. PAUSE POINT Leave flasks under vacuum over night. 
46 Release the vacuum with a flow of nitrogen. 
47 Add 5 ml of freshly distilled pyridine to the 10 ml flask containing 4 using a freshly 
opened plastic syringe with disposable syringe needle. Evaporate the pyridine using a 
rotary evaporator at 40 C. 
48 Repeat step 47 twice. 
49 Fit the 10 ml flask with a gas-inlet adapter and attach it to a nitrogen flow. Purge the 
flask with nitrogen and leave it under an atmosphere of nitrogen. 
50 Add 4 ml of freshly distilled pyridine to the flask using a freshly opened plastic 
syringe with a disposable syringe needle. Heating and sonication might be necessary 
to get 4 into solution. 
CRITICAL STEP The reaction yield is strongly dependent on concentration. Use as 
small amount of solvent as possible. 
51 Add 1 ml of freshly distilled (from CaH2) pyridine to the 5 ml pear-shaped flask 
containing the 4,4’-dimethoxytrityl chloride using a freshly opened plastic syringe 
with disposable syringe needle. 
52 Using a freshly opened plastic syringe fitted with a 20-gauge stainless steel syringe 
needle add the 4,4’-dimethoxytrityl chloride solution dropwise to the stirred solution 
containing 4. 
53 Stir the reaction for 2 h under an atmosphere of nitrogen. 
54 Add 0.5 ml of methanol to the reaction using a plastic syringe with disposable syringe 
needle to stop the reaction. 
55 Remove the magnetic stir bar and evaporate the solvent using a rotary evaporator at 
40 C. 
56 Dissolve the crude product in 5 ml of toluene and evaporate again using a rotary 
evaporator at 40 C. 
57 Repeat step 56. 
58 Pack a chromatography column (25 x 4 cm) with ~50 g silica gel using 5:1:94 
(vol/vol) methanol/pyridine/dichloromethane and cover the top of the column with a 
layer of sand (~1 cm thick). 
59 Dissolve the crude product from step 57 in a minimum volume of the solvent mixture, 
5:1:94 (vol/vol) methanol/pyridine/dichloromethane and add this to the top of the 
column by using a Pasteur pipette. 
60 Elute the column under gravity or under slight pressure with 5:1:94 (vol/vol) 
methanol/pyridine/dichloromethane. The band can be visualized by fluorescence 
using a 365 nm UV-lamp or simply by the colour (yellow). Start collecting fraction 
when the yellow band is about to come out. (Not reacted starting material can be 
eluted after the product has been isolated by running through 8:1:91 (vol/vol) 
methanol/pyridine/dichloromethane.) 
61 Identify fraction containing 5 by TLC. Use thin-layer silica gel on aluminium support 
with 7:93 (vol/vol) methanol/dichloromethane (Rf = 0.15). The bands are visualized 
by fluorescence using a 365 nm UV-lamp. 
62 Evaporate the solvent from the pooled fractions containing 5 using a rotary 
evaporator at 40 C. 
63 Coevaporate twice with toluene using a rotary evaporator at 40 C. PAUSE POINT 
Dry the residual powder over night using a vacuum pump. Product 5 can be stored in 
the dark at -20C for several years. 
64 Add 199 mg (0.313 mmol) of 5 to a 10 ml round-bottom flask containing a magnetic 
stir bar. 
CRITICAL STEP From this point all glass ware should be dried in an oven for at 
least 1 h above 100C before use. 
65 Fit the flask with the rubber septum and insert an argon inlet and a vent consisting of 
a disposable syringe needle. 
66 Turn on a fairly strong argon flow to purge the flask and then reduce the flow to a 
minimum. 
CRITICAL STEP Everything should be done and handled under argon from this 
point. 
67 Using a plastic syringe with disposable syringe needle add 5 ml of freshly distilled 
tetrahydrofuran to the flask. Turn on the magnetic stirrer. 
68 Using a plastic syringe with disposable syringe needle (or a Hamilton syringe) first 
add 0.135 ml (0.785 mmol) of freshly distilled diisopropylethylamine and then 0.07 
ml (0.314 mmol) 2-cyanoethyl-N,N-diisopropylchlorophosphoramidite. 
69 Leave the reaction mixture to stir at room temperature for 30 min. 
70 Transfer the reaction under argon pressure using a cannula (double-ended needle) to a 
separating funnel containing 10 ml dry, degassed ethyl acetate (see Reagent Setup for 
more details). 
71 Wash the solution by extracting it in a seporatory funnel with saturated potassium 
chloride (2 x 5ml). 
72 Dry the ethyl acetate phase with anhydrous sodium sulphate (add the sodium sulphate 
to a stirred solution in aliquots of ~0.5g until the organic solution appears to be clear. 
Leave for at least 5 minutes before filtering). 
73 Filter off the sodium sulphate using a frit funnel and transfer the filtrate to a 25 ml 
round-bottom flask. 
74 Evaporate the ethyl acetate using a rotary evaporator at 50C. 
75 Purge a chromatography column (50 x 1.5 cm) with argon. 
76 Keeping the column under an argon atmosphere pack it with ~50 g silica gel using 1 
% (vol/vol) pyridine (distilled from KOH) in ethyl acetate (dried by decanting from 
anhydrous MgSO4 and then purged with argon before use). 
77 Dissolve the crude from step 74 in a minimum amount of 1 % (vol/vol) pyridine in 
ethyl acetate and load it to the top of the silica gel. Cover the top of the column with a 
layer of sand (~0.5 cm thick). 
78 Elute the column under slight pressure of argon with 1 % (vol/vol) pyridine in ethyl 
acetate. 
79 The product can be visualized as two closely spaced bands on the column by 
fluorescence using a 365 nm UV-lamp (the bands are also coloured yellow but it is 
easier to identify the different bands by fluorescence). Start collecting fractions as the 
first band is approaching. Each fraction eluting from the column was collected in a 
test tube and a blanket of argon was introduced by having an argon line with a syringe 
needle attached passing over each individual test tube just after the fraction is 
collected. 
80 Identify fractions containing both stereomers of the product 6 by TLC. Use thin-layer 
silica gel plates on aluminium support with ethyl acetate (Rf =0.59, 0.47 for the 
stereomers). The bands are visualized by fluorescence using a 365 nm UV-lamp. 
81 Transfer the pooled fractions containing 6 (under argon) to a 250 ml round bottom 
flask and evaporate using a rotary evaporator at 50C. 
82 Re-dissolve the residual oil in 5 ml dry tetrahydrofuran (destilled over sodium). 
83 Transfer the tetrahydrofuran solution (under argon) to a pre-weighed 50 ml round 
bottom flask with a septum fitted. 
84 Evaporate using a rotary evaporator at 50C, re-fit the septum and quickly weigh the 
flask. CRITICAL STEP Do not purge this flask with argon as it will affect weight. 
85 Put three disposable syringe needles in the septum, purge the flask with argon and 
remove the needles. 
PAUSE POINT Product 6 can be stored in the dark at -20C for at least 1 year. 
 
Preparing the tC phosphoramidite 6 for DNA synthesis 
86 Dissolve the phosphoramidite (6) in 8 ml of dry synthesis grade acetonitrile under 
argon. 
87 Take up in a syringe and pull excess amidite back into the syringe body so that the 
needle is empty. 
88 Put a 0.45 micron filter on the syringe and reattach the needle. 
89 Filter the monomer into a weighed clean dry round-bottom flask which has been 
purged with argon. 
CAUTION It is quite difficult to push the solution through the syringe. Make sure the 
syringe needle is fitted securely. 
90 Evaporate off the acetonitrile from the amidite solution on a rotary evaporator at 50C 
and let argon gas in when the flask is removed. 
91 Redissolve the amidite in freshly distilled dichloromethane (alcohol free) under 
argon. Use 1 ml for every 100 mg of amidite. 
92 Syringe the amidite into several dry monomer bottles (of the type used on the DNA 
synthesizer) under argon, 100 mg of amidite per bottle. 
93 Put the monomer bottles in a desiccator, fit each with a septum and put a needle in 
each septum. 
94 Evacuate under high vacuum and leave for 2 hours. 
95 Carefully repressurise the desiccator with argon, remove the bottles from the 
desiccator and purge each with argon. 
PAUSE POINT Monomer bottles can be stored in the dark at -20C for at least 1 
year. 
 
Oligonucleotide synthesis and purification – general description 
96 Oligonucleotides are synthesised on an Applied Biosystems 394 automated 
DNA/RNA synthesiser using a 0.2 mole phosphoramidite cycle of acid-catalysed 
detritylation, coupling, capping and iodine oxidation. The synthesis is performed 
according to standard protocols (for details see Brown, T. and Grzybowski, J.)
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except that the coupling time is increased to 325 s for the tC monomer (A, G, C and T 
coupling time is 25 s). 
97 Purification of oligonucleotides containing tC is performed according to standard 
procedures (for details see Brown, T. and Brown D.J.S.)
29
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ANTICIPATED RESULTS 
Absorption (=4000 M-1cm-1 at long wavelength maximum of tC) and emission spectra of 
derivatives of tC and tC incorporated into oligonucleotides as well as duplex stabilisation 
properties and examples of using tC can be found elsewhere.
19-22
 
 
Typical yields 
Typical isolated yields of the starting material, 2, will be 20-25% over two steps. Typical 
yield of the tC nucleoside, 4, is 10-15 % over the two steps. Typical yield of the DMT-
protection and the phosphytilation is 60-70% and 90-95% respectively. 
 
Analytical data 
Characterization of intermediate 3 is not performed; identification is made by TLC 
(condition given in the procedure section).  
2,4-dihydroxy-5-(2-amino-phenylthio)pyrimidine (1) 
Yield, 30-40%; white powder. UV absorption (0.1 M NaOH) max 294 nm, min 265 nm 
3H-1,3-diaza-2-oxophenothiazine (2) 
Yield, ~70%; yellow powder. UV absorption (0.1 M NaOH) max 235 nm, 309 nm, min 
282 nm, shoulder 253 nm, 352 nm. 
3-(2-deoxy--D-ribofuranosyl)-1,3-diaza-2-oxophenothiazine (4). 
Yield, 10-15% from 2; yellow powder. 
1
H NMR (400 MHz, DMSO-d6)  7.86 (s, 1H), 
7.07 (m, 2H), 6.92 (m, 2H), 6.08 (t, J=6.6 Hz, 1H), 5.22 (1H, OH-not always visible-), 
5.09 (1H, OH -not always visible-), 4.20 (m, 1H), 3.78 (m, 1H), 3.65-3.50 (m, 2H), 2.12 
(m, 1H), 2.02 (m, 1H). 
The main difference for the -anomer in the 1H NMR under the same conditions are:  
6.01 (d, J=7.2 Hz, 1H), 4.20 (m, 2H), 1.89 (d, 1H). Furthermore, the multiplet at 3.65-
3.50 in the -spectrum has shifted and is presumably covered by the water peak at 3.33 
ppm and one of the hydrogen at 2.12 and 2.02 is shifted and presumably covered by the 
solvent residual peak at 2.50 ppm. 
3-[2-deoxy-5-O-(4,4’-dimethoxytrityl)--D-ribofuranosyl]-1,3-diaza-2-
oxophenothiazine (5). 
Yield, 60-70%; yellow powder. 
1
H NMR (400 MHz, DMSO-d6)  7.59 (s, 1H), 7.20-7.40 
(m, 9H), 7.07 (m, 1H), 6.89-6.93 (m, 7H), 6.09 (t, J=6.4 Hz, 1H), 5.32 (1H, OH-not 
always visible-), 4.26 (m, 1H), 3.91 (m, 1H), 3.71 (s, 6H), 3.23 (m, 1H), 3.14 (m, 1H), 
2.11-2.26 (m, 2H). 
3-[2-deoxy-3-O-[2-cyanoethoxy-(N,N-diisopropylamino)-phosphino]-5-O-(4,4’-
dimethoxytrityl)--D-ribofuranosyl]-1,3-diaza-2-oxophenothiazine (6) 
Yield, 90-95% from 5,  
31
P NMR spectrum: P(162 MHz, CDCl3) 149.7, 149.2. 
LRMS (ES+, CH3CN) (m/z) [M+Na
+
] calcd for C45H50N5O7PSNa, 858, found: 858 
(M+Na
+
, 100%). HRMS (ES+, CH3CN) (m/z) [M+H
+
] calcd for C45H51N5O7PS, 
858.3061, found 858.3073. 
 
TIMING 
The starting materials 2 and the 2-deoxy-3,5-di-O-p-toluoyl--D-ribofuranosyl chloride 
are both done in ~2 days and with these at hand the tC nucleoside, 4, will require ~3 days 
and the phosphoramidite, 6, another 2 days. Oligonucleotide synthesis takes 1 day and 
purification takes 3 hours. 
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Figures and Figure Legends 
 
 
 
Figure 1 Scheme for the synthesis of starting material 2, the tC base. 
 
 
 
Figure 2 Scheme for the synthesis of the tC phosphoramidite. 
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